Stock price
Market cap
At each fiscal year end, then the latest quarter end: closing price × shares outstanding.
Show tableHide table
| Period | Market cap |
|---|---|
| FY2016, ended Dec 31, 2016 | $39.2B |
| FY2017, ended Dec 31, 2017 | $49.7B |
| FY2018, ended Dec 31, 2018 | $67.3B |
| FY2019, ended Dec 31, 2019 | $71.9B |
| FY2020, ended Dec 31, 2020 | $65.4B |
| FY2021, ended Dec 31, 2021 | $82.1B |
| FY2022, ended Dec 31, 2022 | $60.5B |
| FY2023, ended Dec 31, 2023 | $75.8B |
| FY2024, ended Dec 31, 2024 | $83.7B |
| FY2025, ended Dec 31, 2025 | $97.9B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $93.8B |
Revenue
By fiscal year, then the trailing 12 months
Show tableHide table
| Period | Revenue |
|---|---|
| FY2016, ended Dec 31, 2016 | $3.60B |
| FY2017, ended Dec 31, 2017 | $3.64B |
| FY2018, ended Dec 31, 2018 | $4.31B |
| FY2019, ended Dec 31, 2019 | $4.87B |
| FY2020, ended Dec 31, 2020 | $4.88B |
| FY2021, ended Dec 31, 2021 | $4.69B |
| FY2022, ended Dec 31, 2022 | $5.02B |
| FY2023, ended Dec 31, 2023 | $5.58B |
| FY2024, ended Dec 31, 2024 | $6.13B |
| FY2025, ended Dec 31, 2025 | $6.52B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $6.97B |
Net income and free cash flow
By fiscal year, then the trailing 12 months. Free cash flow is operating cash flow minus capex.
Show tableHide table
| Period | Net income | Free cash flow |
|---|---|---|
| FY2016, ended Dec 31, 2016 | $1.53B | $1.64B |
| FY2017, ended Dec 31, 2017 | $4.06B | $1.67B |
| FY2018, ended Dec 31, 2018 | $1.96B | $2.32B |
| FY2019, ended Dec 31, 2019 | $2.12B | $2.43B |
| FY2020, ended Dec 31, 2020 | $2.11B | $2.52B |
| FY2021, ended Dec 31, 2021 | $2.64B | $2.28B |
| FY2022, ended Dec 31, 2022 | $2.69B | $2.97B |
| FY2023, ended Dec 31, 2023 | $3.23B | $3.38B |
| FY2024, ended Dec 31, 2024 | $3.53B | $3.60B |
| FY2025, ended Dec 31, 2025 | $4.07B | $4.19B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $4.42B | $4.33B |
Cash and cash equivalents
At each fiscal year end, then the latest quarter end.
Show tableHide table
| Period | Cash and cash equivalents |
|---|---|
| FY2016, ended Dec 31, 2016 | $1.87B |
| FY2017, ended Dec 31, 2017 | $1.90B |
| FY2018, ended Dec 31, 2018 | $1.37B |
| FY2019, ended Dec 31, 2019 | $1.55B |
| FY2020, ended Dec 31, 2020 | $1.63B |
| FY2021, ended Dec 31, 2021 | $2.83B |
| FY2022, ended Dec 31, 2022 | $2.72B |
| FY2023, ended Dec 31, 2023 | $2.91B |
| FY2024, ended Dec 31, 2024 | $2.89B |
| FY2025, ended Dec 31, 2025 | $4.42B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $2.20B |
Total debt
At each fiscal year end, then the latest quarter end. Short- and long-term borrowings, excluding leases.
Show tableHide table
| Period | Total debt |
|---|---|
| FY2016, ended Dec 31, 2016 | — |
| FY2017, ended Dec 31, 2017 | $0 |
| FY2018, ended Dec 31, 2018 | $574M |
| FY2019, ended Dec 31, 2019 | $0 |
| FY2020, ended Dec 31, 2020 | $0 |
| FY2021, ended Dec 31, 2021 | $749M |
| FY2022, ended Dec 31, 2022 | $16.0M |
| FY2023, ended Dec 31, 2023 | $0 |
| FY2024, ended Dec 31, 2024 | $750M |
| FY2025, ended Dec 31, 2025 | $0 |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | — |
Shares outstanding
At each fiscal year end, then the latest quarter end, adjusted for splits. Up 5.4% since FY16.
Show tableHide table
| Period | Shares outstanding |
|---|---|
| FY2016, ended Dec 31, 2016 | 340M |
| FY2017, ended Dec 31, 2017 | 340M |
| FY2018, ended Dec 31, 2018 | 358M |
| FY2019, ended Dec 31, 2019 | 358M |
| FY2020, ended Dec 31, 2020 | 359M |
| FY2021, ended Dec 31, 2021 | 359M |
| FY2022, ended Dec 31, 2022 | 360M |
| FY2023, ended Dec 31, 2023 | 360M |
| FY2024, ended Dec 31, 2024 | 360M |
| FY2025, ended Dec 31, 2025 | 359M |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | 358M |
Buybacks and new shares
By fiscal year, then the trailing 12 months, in dollars. Below zero: bought back. Above zero: issued to employees, sold or used in acquisitions.
Show tableHide table
| Period | Paid to employees | Used in acquisitions |
|---|---|---|
| FY2016, ended Dec 31, 2016 | $66.2M | — |
| FY2017, ended Dec 31, 2017 | $58.0M | — |
| FY2018, ended Dec 31, 2018 | $96.5M | $3.11B |
| FY2019, ended Dec 31, 2019 | $73.1M | — |
| FY2020, ended Dec 31, 2020 | $96.0M | — |
| FY2021, ended Dec 31, 2021 | $75.2M | — |
| FY2022, ended Dec 31, 2022 | $84.3M | — |
| FY2023, ended Dec 31, 2023 | $82.9M | — |
| FY2024, ended Dec 31, 2024 | $89.5M | — |
| FY2025, ended Dec 31, 2025 | $94.8M | — |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $99.6M | — |
Valuation
At current price- Market Cap
- $105B
- P/E
- 23.8×
- Forward P/E
- —. Needs analyst estimates; not available from the current data provider
- Price / Sales
- 15.1×
- Price / Book
- 4.0×
- EV / EBITDA
- —. (Market cap + debt − cash) / EBITDA (TTM)
Growth
Trailing 12 months- Revenue (TTM)
- $6.97B
- Revenue Growth YoY
- 9.0%
- Revenue CAGR 3Y
- 9.1%
- Revenue CAGR 5Y
- 6.0%
- EPS Growth YoY
- 18.2%
- Net Income Growth YoY
- 16.3%
Profitability
Trailing 12 months- Gross Margin
- —
- Operating Margin
- 65.7%
- Net Margin
- 63.3%
- FCF Margin
- 62.1%
- Return on Equity
- 16.1%
Earnings
Trailing 12 months- Net Income
- $4.42B
- EPS (diluted)
- $12.20
- EBITDA
- —. Operating income + depreciation & amortization
- Operating Income
- $4.58B
Balance Sheet
As of Sep 30, 2026- Cash and cash equivalents
- $2.20B
- Total Debt
- —. Short- and long-term borrowings, excluding leases
- Net Cash
- —. Cash − total debt
- Total Assets
- $192B
- Total Liabilities
- $166B
- Shareholders' Equity
- $26.6B
Cash Flow
Trailing 12 months- Operating Cash Flow
- $4.43B
- Capital Expenditure
- $93.7M
- Free Cash Flow
- $4.33B
Dividends and risk
Last 12 months- Dividend Yield
- 3.9%
- Dividend / Share
- $11.30
- Beta (5Y)
- 0.24
Every ratio is calculated from the company’s reported figures.